“Immunotherapy-Induced Endocrinopathies And Their Management In Cancer Patients A Prospective Observational Study”, Journal of Pharmaceutical Negative Results, vol. 12, no. 1, pp. 153–157, Apr. 2021, doi: 10.47750/3625vp43.